C-Rad AB (publ) Cash Flow Conversion Efficiency

Latest as of December 2025: 0.205x

C-Rad AB (publ) cash flow conversion efficiency. Based on the latest financial reports, C-Rad AB (publ) (CRAD-B) has a cash flow conversion efficiency ratio of 0.205x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr71.10 Million ≈ $7.65 Million USD) by net assets (Skr347.20 Million ≈ $37.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of C-Rad AB (publ) (2008–2025)

Cash flow conversion efficiency of C-Rad AB (publ) from 2008 to 2025. This chart illustrates how C-Rad AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View CRAD-B stock price for real-time trading data and today's change.

C-Rad AB (publ) Cash Flow Conversion Ratio Explained

C-Rad AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

C-Rad AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of C-Rad AB (publ) ranked by their cash flow conversion efficiency. Also see C-Rad AB (publ) stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Micropolis Holding Company
NYSE:MCRP
0.063x
Hipages Group Holdings Ltd
AU:HPG
0.304x
Nan Liu Enterprise Co Ltd
TW:6504
0.012x
Renergen Ltd
AU:RLT
-0.015x
Southern Concrete Pile PCL
BK:SCP
0.036x
IX Acquisition Corp
NASDAQ:IXAQ
-0.043x
Choppies Enterprises Ltd
JSE:CHP
0.880x
Lumi Gruppen AS
OL:LUMI
0.171x

Annual Cash Flow Conversion Efficiency for C-Rad AB (publ) (2008–2025)

The table below shows the annual cash flow conversion efficiency of C-Rad AB (publ) from 2008 to 2025. Review free cash flow generation of C-Rad AB (publ) to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr347.20 Million
≈ $37.36 Million
Skr71.10 Million
≈ $7.65 Million
0.205x +121.28%
2024-12-31 Skr324.99 Million
≈ $34.97 Million
Skr30.08 Million
≈ $3.24 Million
0.093x -21.94%
2023-12-31 Skr281.60 Million
≈ $30.30 Million
Skr33.38 Million
≈ $3.59 Million
0.119x +196.73%
2022-12-31 Skr242.54 Million
≈ $26.10 Million
Skr9.69 Million
≈ $1.04 Million
0.040x -49.18%
2021-12-31 Skr231.09 Million
≈ $24.87 Million
Skr18.17 Million
≈ $1.96 Million
0.079x -14.85%
2020-12-31 Skr199.79 Million
≈ $21.50 Million
Skr18.45 Million
≈ $1.99 Million
0.092x -51.38%
2019-12-31 Skr83.33 Million
≈ $8.97 Million
Skr15.83 Million
≈ $1.70 Million
0.190x +285.14%
2018-12-31 Skr93.64 Million
≈ $10.08 Million
Skr-9.61 Million
≈ $-1.03 Million
-0.103x -82.21%
2017-12-31 Skr71.41 Million
≈ $7.68 Million
Skr-4.02 Million
≈ $-432.62K
-0.056x +91.09%
2016-12-31 Skr70.60 Million
≈ $7.60 Million
Skr-44.62 Million
≈ $-4.80 Million
-0.632x -10.29%
2015-12-31 Skr40.05 Million
≈ $4.31 Million
Skr-22.95 Million
≈ $-2.47 Million
-0.573x -38.13%
2014-12-31 Skr40.04 Million
≈ $4.31 Million
Skr-16.61 Million
≈ $-1.79 Million
-0.415x +30.97%
2013-12-31 Skr38.03 Million
≈ $4.09 Million
Skr-22.86 Million
≈ $-2.46 Million
-0.601x +25.17%
2012-12-31 Skr16.26 Million
≈ $1.75 Million
Skr-13.06 Million
≈ $-1.41 Million
-0.803x -41.62%
2011-12-31 Skr36.02 Million
≈ $3.88 Million
Skr-20.43 Million
≈ $-2.20 Million
-0.567x -444.26%
2010-12-31 Skr48.12 Million
≈ $5.18 Million
Skr-5.01 Million
≈ $-539.60K
-0.104x +64.39%
2009-12-31 Skr29.82 Million
≈ $3.21 Million
Skr-8.73 Million
≈ $-939.06K
-0.293x -2.01%
2008-12-31 Skr35.05 Million
≈ $3.77 Million
Skr-10.06 Million
≈ $-1.08 Million
-0.287x --

About C-Rad AB (publ)

ST:CRAD-B Sweden Medical Devices
Market Cap
$82.28 Million
Skr764.53 Million SEK
Market Cap Rank
#19743 Global
#346 in Sweden
Share Price
Skr23.80
Change (1 day)
+1.28%
52-Week Range
Skr21.00 - Skr38.80
All Time High
Skr66.70
About

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solut… Read more